<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <meta http-equiv="X-UA-Compatible" content="ie=edge" />
    <link
        href="https://fonts.googleapis.com/css2?family=Lato:wght@100;300;400&family=Roboto:wght@100;300;500&display=swap"
        rel="stylesheet" />
    <link rel="stylesheet" href="css/style.css" />
    <title>ID Pharma</title>
</head>

<body>
    <div class="container">
        <nav class="navbar">
            <div class="navbar-logo-home">
                <a href="./index-en.html" class="logo-image">
                    <div class="navbar-logo"></div>
                </a>
            </div>
            <div class="navbar-buttons">
                <ul class="menu-list">
                    <li class="list-element">
                        <a href="./index-en.html" class="link">about us</a>
                    </li>
                    <li class="list-element nav-offer">
                        <a href="" class="link">offer</a>
                        <div class="dropdown-menu">
                            <div class="button-border">
                                <a href="./offer-1.html" class="dropdown-item">PHARMACOVIGILANCE</a>
                            </div>
                            <div class="button-border">
                                <a href="./offer-2.html" class="dropdown-item">AUDITS</a>
                            </div>
                            <div class="button-border">
                                <a href="./offer-3.html" class="dropdown-item">MEDICAL INFORMATION</a>
                            </div>
                            <div class="button-border">
                                <a href="./offer-4.html" class="dropdown-item">Local Contact Person in Poland and in
                                    other
                                    countries</a>
                            </div>
                            <div class="button-border">
                                <a href="./offer-5.html" class="dropdown-item">Cosmetovigilance</a>
                            </div>
                            <div class="button-border">
                                <a href="./offer-6.html" class="dropdown-item">Registration of medicinal products</a>
                            </div>
                            <div class="button-border">
                                <a href="./offer-7.html" class="dropdown-item">Medical support for marketing</a>
                            </div>
                        </div>
                    </li>
                    <li class="list-element">
                        <a href="./contact.html" class="link">contact</a>
                    </li>
                    <li class="list-element lang">
                        <a href="./index.html" class="link link-lg link-lg-pl">PL</a>
                    </li>

                    <li class="list-element lang">
                        <a href="./index-en.html" class="link link-lg">EN</a>
                    </li>
                </ul>
            </div>
        </nav>

        <section class="offer-1">
            <div class="offer-title">
                <h2>Pharmacovigilance</h2>
            </div>
            <div class="offer-content">
                <h3>
                    ID Pharma has its own Pharmacovigilance system described with
                    PSMF as well as a qualified person responsible for pharmacovigilance
                    (QPPV) and her deputy (Deputy QPPV), which opens opportunities for:
                </h3>
                <h3>
                    Registration of medicinal products using the pharmacovigilance system
                    and the qualified person responsible for pharmacovigilance (QPPV) provided by ID Pharma;
                </h3>
                <h3>
                    Taking over of the obligations of the MAH in the field of pharmacovigilance
                    in the period during and after product authorization (fully or partially), including:
                </h3>

                <ul>
                    <li>
                        <h4>
                            registration in the EudraVigilance system (ID Pharma possesses appropriate user
                            certificates);
                        </h4>
                    </li>
                    <li>
                        <h4>
                            preparation of selected procedures describing pharmacovigilance activities
                            or a set of procedures in line with the processes required in pharmacovigilance;
                        </h4>
                    </li>
                    <li>
                        <h4>
                            preparation of a complete description of the adverse drug reaction monitoring system
                            (PSMF) tailored to the needs of the company and a summary description (SPS) required in
                            the
                            registration processes;
                        </h4>
                    </li>
                    <li>
                        <h4>
                            preparation of xEVMPD (extended Eudravigilance Medicinal Product Dictionary - in
                            accordance
                            with Article 57(2) of Regulation (EC) No. 726/2004
                        </h4>
                    </li>
                    <li>
                        <h4>
                            risk analysis of the implemented pharmacovigilance system and its adjustment to the
                            structure of organization and legal requirements;
                        </h4>
                    </li>
                    <li>
                        <h4>
                            preparing the company for the Pharmacovigilance inspection;
                        </h4>
                    </li>
                    <li>
                        <h4>
                            management of observations / deficiency after the inspection (CAPA preparation according
                            to
                            the "Deficiency Letters");
                        </h4>
                    </li>
                    <li>
                        <h4>
                            preparation of documentation: periodic reports, RMP with risk minimization, Clinical
                            Expert
                            Statement, Addendum to the Clinical Overview;
                        </h4>
                    </li>
                    <li>
                        <h4>
                            preparation of a risk minimization proposal;
                        </h4>
                    </li>

                    <li>
                        <h4>
                            we ensure 24-hour accessibility in order to report adverse drug reaction;
                        </h4>
                    </li>
                    <li>
                        <h4>
                            processing of adverse drug reaction reports including medical evaluation;
                        </h4>
                    </li>
                    <li>
                        <h4>
                            pharmacovigilance system audits.
                        </h4>
                    </li>
                </ul>
            </div>
        </section>

        <footer class="footer" id="footer">
            <h4>
                Copyright &copy;
                <script>
                    document.write(new Date().getFullYear())
                </script>
            </h4>
        </footer>
    </div>
